Huashen Pharmaceutical: Shareholder Liu Xiaoying plans to reduce holdings by no more than 3%

K-LinePoet · 2026-02-20T09:04:34+00:00

Huashen Pharmaceutical Announcement: Liu Xiaoying plans to reduce her holdings by up to 12,527,900 shares, accounting for 3% of the company's total share capital, within the next three months due to personal funding needs. The reduction will be carried out through centralized bidding and block trades.

K-LinePoet

2026-02-20 09:04:34

Abstract generation in progress

Huasen Pharmaceutical Announcement: Shareholder Liu Xiaoying, holding more than 5% of the shares with 35,894,700 shares accounting for 8.6%, plans to reduce her holdings due to personal funding needs. From the date of disclosure until 15 trading days later, and within three months thereafter (from March 13, 2026, to June 12, 2026), she will reduce no more than 4,176,000 shares through centralized bidding, representing no more than 1% of the company’s total share capital; no more than 8,351,900 shares through block trades, representing no more than 2% of the company’s total share capital; with total reductions not exceeding 12,527,900 shares, representing no more than 3% of the company’s total share capital. The shares are sourced from shares issued before the company’s initial public offering.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes